1-[4-(4-morpholin-4-ylfuro[2,3-d]pyrimidin-6-yl)phenyl]-3-(3-pyridin-3-yl-1,2-oxazol-5-yl)urea;1-[4-(6-morpholin-4-yl-7H-purin-8-yl)phenyl]-3-(3-pyridin-3-yl-1,2-oxazol-5-yl)urea;tris(1-[4-(4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenyl]-3-(3-pyridin-3-yl-1,2-oxazol-5-yl)urea);1-[4-(4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenyl]-3-[3-(1,3-thiazol-2-yl)-1,2-oxazol-5-yl]urea

C147H128N48O19S — CID 160613517

IUPAC1-[4-(4-morpholin-4-ylfuro[2,3-d]pyrimidin-6-yl)phenyl]-3-(3-pyridin-3-yl-1,2-oxazol-5-yl)urea;1-[4-(6-morpholin-4-yl-7H-purin-8-yl)phenyl]-3-(3-pyridin-3-yl-1,2-oxazol-5-yl)urea;tris(1-[4-(4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenyl]-3-(3-pyridin-3-yl-1,2-oxazol-5-yl)urea);1-[4-(4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenyl]-3-[3-(1,3-thiazol-2-yl)-1,2-oxazol-5-yl]urea
SMILESO=C(Nc1ccc(-c2cc3c(N4CCOCC4)ncnc3[nH]2)cc1)Nc1cc(-c2cccnc2)no1.O=C(Nc1ccc(-c2cc3c(N4CCOCC4)ncnc3[nH]2)cc1)Nc1cc(-c2cccnc2)no1.O=C(Nc1ccc(-c2cc3c(N4CCOCC4)ncnc3[nH]2)cc1)Nc1cc(-c2cccnc2)no1.O=C(Nc1ccc(-c2cc3c(N4CCOCC4)ncnc3[nH]2)cc1)Nc1cc(-c2nccs2)no1.O=C(Nc1ccc(-c2cc3c(N4CCOCC4)ncnc3o2)cc1)Nc1cc(-c2cccnc2)no1.O=C(Nc1ccc(-c2nc3ncnc(N4CCOCC4)c3[nH]2)cc1)Nc1cc(-c2cccnc2)no1
InChIInChI=1S/3C25H22N8O3.C25H21N7O4.C24H21N9O3.C23H20N8O3S/c3*34-25(31-22-13-21(32-36-22)17-2-1-7-26-14-17)29-18-5-3-16(4-6-18)20-12-19-23(30-20)27-15-28-24(19)33-8-10-35-11-9-33;33-25(30-22-13-20(31-36-22)17-2-1-7-26-14-17)29-18-5-3-16(4-6-18)21-12-19-23(27-15-28-24(19)35-21)32-8-10-34-11-9-32;34-24(29-19-12-18(32-36-19)16-2-1-7-25-13-16)28-17-5-3-15(4-6-17)21-30-20-22(31-21)26-14-27-23(20)33-8-10-35-11-9-33;32-23(29-19-12-18(30-34-19)22-24-5-10-35-22)27-15-3-1-14(2-4-15)17-11-16-20(28-17)25-13-26-21(16)31-6-8-33-9-7-31/h3*1-7,12-15H,8-11H2,(H,27,28,30)(H2,29,31,34);1-7,12-15H,8-11H2,(H2,29,30,33);1-7,12-14H,8-11H2,(H2,28,29,34)(H,26,27,30,31);1-5,10-13H,6-9H2,(H,25,26,28)(H2,27,29,32)
InChIKeyRFUAGIZEEJGYNA-UHFFFAOYSA-N
MW2903.02 g/mol
LogP24.65
Rot. Bonds30

About 1-[4-(4-morpholin-4-ylfuro[2,3-d]pyrimidin-6-yl)phenyl]-3-(3-pyridin-3-yl-1,2-oxazol-5-yl)urea;1-[4-(6-morpholin-4-yl-7H-purin-8-yl)phenyl]-3-(3-pyridin-3-yl-1,2-oxazol-5-yl)urea;tris(1-[4-(4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenyl]-3-(3-pyridin-3-yl-1,2-oxazol-5-yl)urea);1-[4-(4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenyl]-3-[3-(1,3-thiazol-2-yl)-1,2-oxazol-5-yl]urea

1-[4-(4-morpholin-4-ylfuro[2,3-d]pyrimidin-6-yl)phenyl]-3-(3-pyridin-3-yl-1,2-oxazol-5-yl)urea;1-[4-(6-morpholin-4-yl-7H-purin-8-yl)phenyl]-3-(3-pyridin-3-yl-1,2-oxazol-5-yl)urea;tris(1-[4-(4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenyl]-3-(3-pyridin-3-yl-1,2-oxazol-5-yl)urea);1-[4-(4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenyl]-3-[3-(1,3-thiazol-2-yl)-1,2-oxazol-5-yl]urea (PubChem CID 160613517) has the molecular formula C147H128N48O19S and a molecular weight of 2903.02 g/mol. Its IUPAC name is 1-[4-(4-morpholin-4-ylfuro[2,3-d]pyrimidin-6-yl)phenyl]-3-(3-pyridin-3-yl-1,2-oxazol-5-yl)urea;1-[4-(6-morpholin-4-yl-7H-purin-8-yl)phenyl]-3-(3-pyridin-3-yl-1,2-oxazol-5-yl)urea;tris(1-[4-(4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenyl]-3-(3-pyridin-3-yl-1,2-oxazol-5-yl)urea);1-[4-(4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenyl]-3-[3-(1,3-thiazol-2-yl)-1,2-oxazol-5-yl]urea.

Molecular Properties

Compound Name1-[4-(4-morpholin-4-ylfuro[2,3-d]pyrimidin-6-yl)phenyl]-3-(3-pyridin-3-yl-1,2-oxazol-5-yl)urea;1-[4-(6-morpholin-4-yl-7H-purin-8-yl)phenyl]-3-(3-pyridin-3-yl-1,2-oxazol-5-yl)urea;tris(1-[4-(4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenyl]-3-(3-pyridin-3-yl-1,2-oxazol-5-yl)urea);1-[4-(4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenyl]-3-[3-(1,3-thiazol-2-yl)-1,2-oxazol-5-yl]urea
PubChem CID160613517
Molecular FormulaC147H128N48O19S
Molecular Weight2903.02 g/mol
Exact Mass2901.02
IUPAC Name1-[4-(4-morpholin-4-ylfuro[2,3-d]pyrimidin-6-yl)phenyl]-3-(3-pyridin-3-yl-1,2-oxazol-5-yl)urea;1-[4-(6-morpholin-4-yl-7H-purin-8-yl)phenyl]-3-(3-pyridin-3-yl-1,2-oxazol-5-yl)urea;tris(1-[4-(4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenyl]-3-(3-pyridin-3-yl-1,2-oxazol-5-yl)urea);1-[4-(4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenyl]-3-[3-(1,3-thiazol-2-yl)-1,2-oxazol-5-yl]urea
SMILESO=C(Nc1ccc(-c2cc3c(N4CCOCC4)ncnc3[nH]2)cc1)Nc1cc(-c2cccnc2)no1.O=C(Nc1ccc(-c2cc3c(N4CCOCC4)ncnc3[nH]2)cc1)Nc1cc(-c2cccnc2)no1.O=C(Nc1ccc(-c2cc3c(N4CCOCC4)ncnc3[nH]2)cc1)Nc1cc(-c2cccnc2)no1.O=C(Nc1ccc(-c2cc3c(N4CCOCC4)ncnc3[nH]2)cc1)Nc1cc(-c2nccs2)no1.O=C(Nc1ccc(-c2cc3c(N4CCOCC4)ncnc3o2)cc1)Nc1cc(-c2cccnc2)no1.O=C(Nc1ccc(-c2nc3ncnc(N4CCOCC4)c3[nH]2)cc1)Nc1cc(-c2cccnc2)no1
InChIInChI=1S/3C25H22N8O3.C25H21N7O4.C24H21N9O3.C23H20N8O3S/c3*34-25(31-22-13-21(32-36-22)17-2-1-7-26-14-17)29-18-5-3-16(4-6-18)20-12-19-23(30-20)27-15-28-24(19)33-8-10-35-11-9-33;33-25(30-22-13-20(31-36-22)17-2-1-7-26-14-17)29-18-5-3-16(4-6-18)21-12-19-23(27-15-28-24(19)35-21)32-8-10-34-11-9-32;34-24(29-19-12-18(32-36-19)16-2-1-7-25-13-16)28-17-5-3-15(4-6-17)21-30-20-22(31-21)26-14-27-23(20)33-8-10-35-11-9-33;32-23(29-19-12-18(30-34-19)22-24-5-10-35-22)27-15-3-1-14(2-4-15)17-11-16-20(28-17)25-13-26-21(16)31-6-8-33-9-7-31/h3*1-7,12-15H,8-11H2,(H,27,28,30)(H2,29,31,34);1-7,12-15H,8-11H2,(H2,29,30,33);1-7,12-14H,8-11H2,(H2,28,29,34)(H,26,27,30,31);1-5,10-13H,6-9H2,(H,25,26,28)(H2,27,29,32)
InChIKeyRFUAGIZEEJGYNA-UHFFFAOYSA-N
XLogP24.65
TPSA814.78 Ų
H-Bond Donors17
H-Bond Acceptors51
Rotatable Bonds30
Heavy Atoms215
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002903.02
LogP ≤ 524.65
H-Bond Donors ≤ 517
H-Bond Acceptors ≤ 1051

Analyze 1-[4-(4-morpholin-4-ylfuro[2,3-d]pyrimidin-6-yl)phenyl]-3-(3-pyridin-3-yl-1,2-oxazol-5-yl)urea;1-[4-(6-morpholin-4-yl-7H-purin-8-yl)phenyl]-3-(3-pyridin-3-yl-1,2-oxazol-5-yl)urea;tris(1-[4-(4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenyl]-3-(3-pyridin-3-yl-1,2-oxazol-5-yl)urea);1-[4-(4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenyl]-3-[3-(1,3-thiazol-2-yl)-1,2-oxazol-5-yl]urea with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 1-[4-(4-morpholin-4-ylfuro[2,3-d]pyrimidin-6-yl)phenyl]-3-(3-pyridin-3-yl-1,2-oxazol-5-yl)urea;1-[4-(6-morpholin-4-yl-7H-purin-8-yl)phenyl]-3-(3-pyridin-3-yl-1,2-oxazol-5-yl)urea;tris(1-[4-(4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenyl]-3-(3-pyridin-3-yl-1,2-oxazol-5-yl)urea);1-[4-(4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenyl]-3-[3-(1,3-thiazol-2-yl)-1,2-oxazol-5-yl]urea?
The IUPAC name of 1-[4-(4-morpholin-4-ylfuro[2,3-d]pyrimidin-6-yl)phenyl]-3-(3-pyridin-3-yl-1,2-oxazol-5-yl)urea;1-[4-(6-morpholin-4-yl-7H-purin-8-yl)phenyl]-3-(3-pyridin-3-yl-1,2-oxazol-5-yl)urea;tris(1-[4-(4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenyl]-3-(3-pyridin-3-yl-1,2-oxazol-5-yl)urea);1-[4-(4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenyl]-3-[3-(1,3-thiazol-2-yl)-1,2-oxazol-5-yl]urea (CID 160613517) is 1-[4-(4-morpholin-4-ylfuro[2,3-d]pyrimidin-6-yl)phenyl]-3-(3-pyridin-3-yl-1,2-oxazol-5-yl)urea;1-[4-(6-morpholin-4-yl-7H-purin-8-yl)phenyl]-3-(3-pyridin-3-yl-1,2-oxazol-5-yl)urea;tris(1-[4-(4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenyl]-3-(3-pyridin-3-yl-1,2-oxazol-5-yl)urea);1-[4-(4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenyl]-3-[3-(1,3-thiazol-2-yl)-1,2-oxazol-5-yl]urea.
What is the SMILES notation for 1-[4-(4-morpholin-4-ylfuro[2,3-d]pyrimidin-6-yl)phenyl]-3-(3-pyridin-3-yl-1,2-oxazol-5-yl)urea;1-[4-(6-morpholin-4-yl-7H-purin-8-yl)phenyl]-3-(3-pyridin-3-yl-1,2-oxazol-5-yl)urea;tris(1-[4-(4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenyl]-3-(3-pyridin-3-yl-1,2-oxazol-5-yl)urea);1-[4-(4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenyl]-3-[3-(1,3-thiazol-2-yl)-1,2-oxazol-5-yl]urea?
The canonical SMILES for 1-[4-(4-morpholin-4-ylfuro[2,3-d]pyrimidin-6-yl)phenyl]-3-(3-pyridin-3-yl-1,2-oxazol-5-yl)urea;1-[4-(6-morpholin-4-yl-7H-purin-8-yl)phenyl]-3-(3-pyridin-3-yl-1,2-oxazol-5-yl)urea;tris(1-[4-(4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenyl]-3-(3-pyridin-3-yl-1,2-oxazol-5-yl)urea);1-[4-(4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenyl]-3-[3-(1,3-thiazol-2-yl)-1,2-oxazol-5-yl]urea is O=C(Nc1ccc(-c2cc3c(N4CCOCC4)ncnc3[nH]2)cc1)Nc1cc(-c2cccnc2)no1.O=C(Nc1ccc(-c2cc3c(N4CCOCC4)ncnc3[nH]2)cc1)Nc1cc(-c2cccnc2)no1.O=C(Nc1ccc(-c2cc3c(N4CCOCC4)ncnc3[nH]2)cc1)Nc1cc(-c2cccnc2)no1.O=C(Nc1ccc(-c2cc3c(N4CCOCC4)ncnc3[nH]2)cc1)Nc1cc(-c2nccs2)no1.O=C(Nc1ccc(-c2cc3c(N4CCOCC4)ncnc3o2)cc1)Nc1cc(-c2cccnc2)no1.O=C(Nc1ccc(-c2nc3ncnc(N4CCOCC4)c3[nH]2)cc1)Nc1cc(-c2cccnc2)no1.
What is the InChIKey of 1-[4-(4-morpholin-4-ylfuro[2,3-d]pyrimidin-6-yl)phenyl]-3-(3-pyridin-3-yl-1,2-oxazol-5-yl)urea;1-[4-(6-morpholin-4-yl-7H-purin-8-yl)phenyl]-3-(3-pyridin-3-yl-1,2-oxazol-5-yl)urea;tris(1-[4-(4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenyl]-3-(3-pyridin-3-yl-1,2-oxazol-5-yl)urea);1-[4-(4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenyl]-3-[3-(1,3-thiazol-2-yl)-1,2-oxazol-5-yl]urea?
The InChIKey is RFUAGIZEEJGYNA-UHFFFAOYSA-N. The full InChI is InChI=1S/3C25H22N8O3.C25H21N7O4.C24H21N9O3.C23H20N8O3S/c3*34-25(31-22-13-21(32-36-22)17-2-1-7-26-14-17)29-18-5-3-16(4-6-18)20-12-19-23(30-20)27-15-28-24(19)33-8-10-35-11-9-33;33-25(30-22-13-20(31-36-22)17-2-1-7-26-14-17)29-18-5-3-16(4-6-18)21-12-19-23(27-15-28-24(19)35-21)32-8-10-34-11-9-32;34-24(29-19-12-18(32-36-19)16-2-1-7-25-13-16)28-17-5-3-15(4-6-17)21-30-20-22(31-21)26-14-27-23(20)33-8-10-35-11-9-33;32-23(29-19-12-18(30-34-19)22-24-5-10-35-22)27-15-3-1-14(2-4-15)17-11-16-20(28-17)25-13-26-21(16)31-6-8-33-9-7-31/h3*1-7,12-15H,8-11H2,(H,27,28,30)(H2,29,31,34);1-7,12-15H,8-11H2,(H2,29,30,33);1-7,12-14H,8-11H2,(H2,28,29,34)(H,26,27,30,31);1-5,10-13H,6-9H2,(H,25,26,28)(H2,27,29,32).
What are the key properties of 1-[4-(4-morpholin-4-ylfuro[2,3-d]pyrimidin-6-yl)phenyl]-3-(3-pyridin-3-yl-1,2-oxazol-5-yl)urea;1-[4-(6-morpholin-4-yl-7H-purin-8-yl)phenyl]-3-(3-pyridin-3-yl-1,2-oxazol-5-yl)urea;tris(1-[4-(4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenyl]-3-(3-pyridin-3-yl-1,2-oxazol-5-yl)urea);1-[4-(4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenyl]-3-[3-(1,3-thiazol-2-yl)-1,2-oxazol-5-yl]urea?
1-[4-(4-morpholin-4-ylfuro[2,3-d]pyrimidin-6-yl)phenyl]-3-(3-pyridin-3-yl-1,2-oxazol-5-yl)urea;1-[4-(6-morpholin-4-yl-7H-purin-8-yl)phenyl]-3-(3-pyridin-3-yl-1,2-oxazol-5-yl)urea;tris(1-[4-(4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenyl]-3-(3-pyridin-3-yl-1,2-oxazol-5-yl)urea);1-[4-(4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenyl]-3-[3-(1,3-thiazol-2-yl)-1,2-oxazol-5-yl]urea has a molecular weight of 2903.02 g/mol, XLogP of 24.65, 30 rotatable bonds, 17 hydrogen bond donors, and 51 hydrogen bond acceptors.
Where does this data come from?
All data for 1-[4-(4-morpholin-4-ylfuro[2,3-d]pyrimidin-6-yl)phenyl]-3-(3-pyridin-3-yl-1,2-oxazol-5-yl)urea;1-[4-(6-morpholin-4-yl-7H-purin-8-yl)phenyl]-3-(3-pyridin-3-yl-1,2-oxazol-5-yl)urea;tris(1-[4-(4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenyl]-3-(3-pyridin-3-yl-1,2-oxazol-5-yl)urea);1-[4-(4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenyl]-3-[3-(1,3-thiazol-2-yl)-1,2-oxazol-5-yl]urea is sourced from PubChem (CID 160613517), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).